Cargando…
Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis
INTRODUCTION: Despite the growing evidence on efficacy, few economic evaluations have evaluated the cost-utility of Pidotimod (PDT) supplementation to decrease the probability of recurrent respiratory tract infections in children. This study aimed to determine the cost-utility of PDT to reduce the i...
Autores principales: | Buendía, Jefferson Antonio, Guerrero Patiño, Diana, Lindarte, Erika Fernanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219210/ https://www.ncbi.nlm.nih.gov/pubmed/35739542 http://dx.doi.org/10.1186/s12890-022-02029-4 |
Ejemplares similares
-
OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis
por: Buendía, Jefferson Antonio, et al.
Publicado: (2022) -
Cost-utility of vitamin D supplementation to prevent acute respiratory infections in children
por: Buendía, Jefferson Antonio, et al.
Publicado: (2023) -
Costs of Respiratory Syncytial Virus Hospitalizations in Colombia
por: Buendía, Jefferson Antonio, et al.
Publicado: (2020) -
Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma
por: Buendía, Jefferson Antonio, et al.
Publicado: (2021) -
TLR4 Gene Polymorphisms Interaction With Ascaris Infection in Severe RSV Bronchiolitis
por: Buendía, Jefferson Antonio, et al.
Publicado: (2022)